» Articles » PMID: 27752802

Protective Effects of Thymoquinone Against Convulsant Activity Induced by Lithium-Pilocarpine in a Model of Status Epilepticus

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2016 Oct 19
PMID 27752802
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammation plays a pivotal role in status epilepticus (SE). Thymoquinone (TQ) is a bioactive monomer extracted from black seed (Nigella sativa) oil, which has anti-inflammatory properties in the context of various diseases. This study explored the protective effects of TQ in SE and used a lithium-pilocarpine model of SE to investigate the underlying mechanism, which was related to inflammation mediated by the NF-κB signaling pathway. In the present study, latency to SE increased in the TQ-pretreated group compared with the SE group, and the incidence of SE was significantly reduced. The seizure severity score measured on the Racine scale was significantly decreased in the TQ group compared with the SE group. Moreover, the results of the behavioral tests suggested that TQ may also have a protective effect on learning and memory functions. Finally, we further investigated the protective mechanism of TQ. The results showed that TQ-pretreatment significantly downregulated the protein levels of COX-2 and TNF-α in the brain, in a manner mediated by the NF-κB signaling pathway. These findings demonstrate that TQ attenuates convulsant activity via an anti- inflammation signaling pathway in a model of SE.

Citing Articles

Cognitive comorbidities in the rat pilocarpine model of epilepsy.

Guarino A, Pignata P, Lovisari F, Asth L, Simonato M, Soukupova M Front Neurol. 2024; 15:1392977.

PMID: 38872822 PMC: 11171745. DOI: 10.3389/fneur.2024.1392977.


Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease.

Ozsoy S, Cakir Z, Akcay E, Gevrek F Turk J Med Sci. 2023; 53(4):894-901.

PMID: 38031940 PMC: 10760553. DOI: 10.55730/1300-0144.5653.


Therapeutic potential of thymoquinone and its nanoformulations in neuropsychological disorders: a comprehensive review on molecular mechanisms in preclinical studies.

Saadat M, Dahmardeh N, Sheikhbahaei F, Mokhtari T Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(6):3541-3564.

PMID: 38010395 DOI: 10.1007/s00210-023-02832-8.


Treating Epilepsy with Natural Products: Nonsense or Possibility?.

Malanik M, culenova M, Sychrova A, Skiba A, Skalicka-Wozniak K, Smejkal K Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37630977 PMC: 10459181. DOI: 10.3390/ph16081061.


Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review.

Sadeghi E, Imenshahidi M, Hosseinzadeh H Mol Biol Rep. 2023; 50(6):5439-5454.

PMID: 37155017 DOI: 10.1007/s11033-023-08363-y.


References
1.
Ullah I, Badshah H, Naseer M, Lee H, Kim M . Thymoquinone and vitamin C attenuates pentylenetetrazole-induced seizures via activation of GABAB1 receptor in adult rats cortex and hippocampus. Neuromolecular Med. 2014; 17(1):35-46. DOI: 10.1007/s12017-014-8337-3. View

2.
Shih R, Wang C, Yang C . NF-kappaB Signaling Pathways in Neurological Inflammation: A Mini Review. Front Mol Neurosci. 2016; 8:77. PMC: 4683208. DOI: 10.3389/fnmol.2015.00077. View

3.
Meng X, Tan L, Tan M, Jiang T, Tan C, Li M . Inhibition of the NLRP3 inflammasome provides neuroprotection in rats following amygdala kindling-induced status epilepticus. J Neuroinflammation. 2014; 11:212. PMC: 4275944. DOI: 10.1186/s12974-014-0212-5. View

4.
Vezzani A, French J, Bartfai T, Baram T . The role of inflammation in epilepsy. Nat Rev Neurol. 2010; 7(1):31-40. PMC: 3378051. DOI: 10.1038/nrneurol.2010.178. View

5.
Gokce E, Kahveci R, Gokce A, Cemil B, Aksoy N, Sargon M . Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis. J Neurosurg Spine. 2016; 24(6):949-59. DOI: 10.3171/2015.10.SPINE15612. View